Exicure, Inc. received notice from Nasdaq that it is no longer in compliance with Nasdaq's compensation committee requirements and independent director and audit committee requirements. The company has a cure period to regain compliance and plans to submit a plan to Nasdaq. Additionally, the company appointed new directors to the board.